Cancer, Bladder Completed Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Bladder Cancers / Bladder Cancer / Malignant neoplasm of urinary bladder NOS / Bladder neoplasms malignant / Malignant neoplasm of bladder / Urinary Bladder Cancer / Malignant neoplasm of bladder, part unspecified / Bladder cancer NOS / Ca bladder

IndicationStatusPhase
DBCOND0092003 (Cancer, Bladder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004203Oxaliplatin in Treating Patients With Metastatic Bladder CancerTreatment
NCT00186277Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder CancerTreatment